Is organ preservation in rectal cancer ready for prime time?

Lancet. 2018 Jun 23;391(10139):2480-2482. doi: 10.1016/S0140-6736(18)31324-2.

Authors

Paris Tekkis¹, Diana Tait², David Cunningham², Gina Brown³

Affiliations

¹ Gastrointestinal Unit, The Royal Marsden Hospital, London SW3 6JJ, UK; Department of Surgery and Cancer, Imperial College London, London, UK. Electronic address: p.tekkis@imperial.ac.uk.
² Gastrointestinal Unit, The Royal Marsden Hospital, London SW3 6JJ, UK.
³ Department of Radiology, The Royal Marsden Hospital, London, UK.

PMID: 29976455
DOI: 10.1016/S0140-6736(18)31324-2

No abstract available

Publication types

Comment

MeSH terms

Chemoradiotherapy
Humans
Neoadjuvant Therapy
Organ Preservation*
Rectal Neoplasms / surgery*